Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports high selectivity and binding affinity to specific enzyme active sites. Commonly employed in medicinal chemistry for constructing complex molecules requiring chiral pyrrolidine scaffolds. Also utilized in research settings to explore structure-activity relationships in drug candidates targeting inflammatory and neurodegenerative diseases.